NSCLC

Latest News

Medicaid Enrollees Appear To Be Missing Out on Targeted Treatment for NSCLC, Harvard Researchers Find
Medicaid Enrollees Appear To Be Missing Out on Targeted Treatment for NSCLC, Harvard Researchers Find

January 25th 2023

1 out 3 Medicaid patients who might have benefited from targeted therapy —mainly Tagrisso and Alecensa — for metastatic lung cancer did not receive it, according to estimates by a trio Harvard-affiliated researchers.

Keytruda Plus Platinum-based Chemotherapy Comes Out on Top in Network Meta-analysis
Keytruda Plus Platinum-based Chemotherapy Comes Out on Top in Network Meta-analysis

September 27th 2021

The Mainstreaming  of Targeted Lung Cancer Treatment
The Mainstreaming of Targeted Lung Cancer Treatment

September 14th 2021

Research Identifies Mutational Signatures of Nonsmall Cell Lung Cancer Tumors in Never Smokers
Research Identifies Mutational Signatures of Nonsmall Cell Lung Cancer Tumors in Never Smokers

September 9th 2021

Hypofractionated Radiotherapy Fails to Extend Survival in NSCLC Patients Ineligible for Concurrent Chemoradiotherapy
Hypofractionated Radiotherapy Fails to Extend Survival in NSCLC Patients Ineligible for Concurrent Chemoradiotherapy

September 1st 2021

Video Interviews
Latest CME Events & Activities

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...

September 6, 2025

Register Now!

What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….

View More

Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies

View More

Community Practice Connections™: 25th Annual International Lung Cancer Congress

View More

Community Practice Connections™: 8th Annual School of Nursing Oncology™

View More

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies

View More

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

View More

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

View More

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

View More

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

23rd Annual Winter Lung Cancer Conference®

January 23-25, 2026

Register Now!

Burst CME™: The Role of HER2 in NSCLC and Implications for Emerging Treatment Strategies

View More

Future Directions in Treating SCLC and LCNEC-L: The Impact of DLL3

View More

42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow

View More

Community Practice Connections™: 19th Annual New York Lung Cancers Symposium®

View More

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

View More

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

View More

3rd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference

View More

Community Practice Connections™: Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC

View More

More News

© 2025 MJH Life Sciences

All rights reserved.